Patent foramen ovale closure for Migraine

Circulation: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 468-474

  Reisman, Mark ^a   Fuller, Cindy J ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

BRAIN BLOOD FLOW; DISABILITY; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GRAY MATTER; HEART RIGHT LEFT SHUNT; HEREDITY; HUMAN; MIGRAINE; MIGRAINE WITH AURA; NOTE; PATENT FORAMEN OVALE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; STROKE; SYMPTOM; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; TREATMENT OUTCOME; WHITE MATTER;

CARDIAC SURGICAL PROCEDURES; FORAMEN OVALE, PATENT; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIGRAINE DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; STROKE;

EID: 77953670338     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.109.876128     Document Type: Note

References (50)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: II edition. Cephalalgia. 2004;24:9-160.
2. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349.
3. Cutrer FM, Huerter K. Migraine aura. Neurologist. 2007;13:118-125.
4. Rigatelli G. Migraine and patent foramen ovale: connecting flight or one-way ticket? Expert Rev Neuro Ther. 2008;8:1331-1337.
5. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005; 45:493-495.
6. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000;356:1648-1651.
7. Jesurum JT, Fuller CJ, Kim CJ, Krabill KA, Spencer MP, Olsen JV, Likosky WH, Reisman M. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt. Am J Cardiol. 2008;102:916-920.
8. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008;28: 531-540.
9. Rigatelli G, Cardaioli P, Giordan M, Dell'Avvocata F, Braggion G, Chianaglia M, Roncon L. Transcatheter interatrial shunt closure as a cure for migraine: can it be justified by paradoxical embolism-risk-driven criteria? Am J Med Sci. 2009;337:179-181.
10. Harms V, Reisman M, Fuller CJ, Spencer MP, Olsen JV, Krabill KA, Gray WA, Jesurum JT. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Am J Cardiol. 2007;99:1312-1315.
11. Meier B. Stroke and migraine: a cardiologist's headache. Heart. 2009; 95:595-602.
12. Lipton RB. Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology. 2009;72:S3-S7.
13. Loder E, Biondi D. Disease modification in migraine: a concept that has come of age? Headache. 2003;43:135-143.
14. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 2005;128:2068-2077.
15. Rocca MA, Ceccarelli A, Falini A, Colombo B, Tortorella P, Bernasconi L, Comi G, Scotti G, Filippi M. Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke. 2006;37:1765-1770.
16. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of rightto-left shunting predict migraine and stroke: data from 420 patients. Neurology. 2006;66:765-767.
17. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lipscombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) Trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397-1404.
18. Jesurum JT, Fuller CJ, Velez CA, Spencer MP, Krabill KA, Likosky WH, Gray WA, Olsen JV, Reisman M. Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal features. J Headache Pain. 2007;8:209-216.
19. Rigatelli G, Dell'avvocata F, Cardaioli P, Giordan M, Braggion G, Aggio S, Roncon L, Chinaglia M. Migraine-patent foramen ovale connection: role of prominent Eustachian valve and large Chiari network in migrainous patients. Am J Med Sci. 2008;336:458-461.
20. Carerj S, Narbone MC, Zito C, Serra S, Coglitore S, Pugliatti P, Luzza F, Arrigo F, Oreto G. Prevalence of atrial septal aneurysm in patients with migraine: an echocardiographic study. Headache. 2003;43:725-728.
21. Rodes-Cabau J, Molina C, Serrano-Munuera C, Casaldaliga J, Alvarez-Sabin J, Evangelista A, Soler-Soler J. Migraine with aura related to the percutaneous closure of an atrial septal defect. Catheter Cardiovasc Interv. 2003;60:540-542.
22. Jesurum JT, Fuller CJ, Lucas SM, Murinova N, Truva CM, McGee EA, Reisman M. Response to aspirin in migraineurs (RAM). Neurology. 2009;72:A91 Abstract.
23. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005;91:1173-1175.
24. Gillis CN, Pitt BR. The fate of circulating amines within the pulmonary circulation. Annu Rev Physiol. 1982;44:269-281.
25. Levitsky MG. Pulmonary Physiology. New York: McGraw-Hill; 2007.
26. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007;13:39-44.
27. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, Elliott DA, Barnett L, Koentgen F, Robb L, Feneley M, Harvey RP. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res. 2000;87:888-895.
28. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart. 2004;90:1315-1320.
29. Arquizan C, Coste J, Touboul PJ, Mas JL. Is patent foramen ovale a family trait? A transcranial Doppler sonographic study. Stroke. 2001;32: 1563-1566.
30. Anzola GP, Meneghetti G, Zanferrari C, Adami A, Dinia L, Del Sette M. Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia. 2008;28:360-366.
31. Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Volta GD, Archetti S, Zavarise P, Camarda C, Gasparotti R, Magoni M, Camarda R, Padovani A. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 2007;38:3145-3151.
32. Giardini A, Donti A, Formigari R, Salomone L, Prandstraller D, Bonvicini M, Palareti G, Guidetti D, Gaddi O, Picchio FM. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J. 2006;151:922 e921-e925.
33. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol. 2008;7:246-255.
34. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol. 2004; 61:1366-1368.
35. Scher AI, Gudmundsson LS, Sigurdsson S, Ghambaryan A, Aspelund T, Eiriksdottir G, van Buchem MA, Gudnason V, Launer LJ. Migraine headache in middle age and late-life brain infarcts. JAMA. 2009;301: 2563-2570.
36. Vigna C, Marchese N, Inchingolo V, Giannatempo GM, Pacilli MA, Di Viesti P, Impagliatelli M, Natali R, Russo A, Fanelli R, Loperfido F. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: A case-control study. J Am Coll Cardiol Interv. 2009;2:107-113.
37. Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001;41:629-637.
38. Relja G, Granato A, Ukmar M, Ferretti G, Antonello RM, Zorzon M. Persistent aura without infarction: decription of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia. 2005;25:56-59.
39. Venketasubramanian N, Sacco RL, Di Tullio M, Sherman D, Homma S, Mohr JP. Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology. 1993;43:1533-1535.
40. Hoekstra-van Dalen RA, Cillessen JP, Kappelle LJ, van Gijn J. Cerebral infarcts associated with migraine: clinical features, risk factors and follow-up. J Neurol. 1996;243:511-515.
41. Nozari A, Dilekozh E, Sukhotinsky I, Stein T, Eikermann-Haerter K, Liu C, Ayata C, Moskowitz MA. Microembolization triggers cortical spreading depression both with and without microinfarcts: implications for a migraine-stroke continuum. Stroke. 2009;40:e217 Abstract.
42. Marchione P, Ghiotto N, Sances G, Guaschino E, Bosone D, Nappi G, Giacomini P. Clinical implications of patent foramen ovale in migraine with aura. Funct Neurol. 2008;23:201-205.
43. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330:63-66.
44. Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ. 2008;337:a636.
45. Becker C, Brobert GP, Almqvist PM, Johansson S, Jick SS, Meier CR. Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache. 2007;47:1374-1384.
46. Schwaiger J, Kiechl S, Stockner H, Knoflach M, Werner P, Rungger G, Gasperi A, Willeit J. Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology. 2008;71: 937-943.
47. Diener HC, Schorn CF, Bingel U, Dodick DW. The importance of placebo in headache research. Cephalalgia. 2008;28:1003-1011.
48. Howland RH. Understanding the placebo effect. Part 1: placebo use in clinical trials. J Psychosoc Nurs Ment Health Serv. 2008;46:17-20.
49. Carroll JD. Migraine intervention with STARFlex technology trial: a controversial trial of migraine and patent foramen ovale closure. Circulation. 2008;117:1358-1360.
50. Schulman EA, Peterlin BL, Lake AE III, Lipton RB, Hanlon A, Siegel S, Levin M, Goadsby PJ, Markley HG. Defining refractory migraine: results of the RHSIS Survey of Am Headache Society members. Headache. 2009;49:509-518.